Innovative framework enhances clinician trust and transparency in AI-driven healthcare diagnostics, driving broader adoption of AI across clinical practices REDMOND, WA, March 12, 2025 – Pattern Computer®, Inc. (“Pattern” or “the Company”), a leader in cutting-edge explainable AI (XAI) research, [...]
The Pattern Discovery Engine™ and the ProSpectral™ platform will be deployed to discover new drivers of human health REDMOND, Wash., Dec. 06, 2024 -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that it has entered into a [...]
Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Pattern identified a novel drug target that is not actively expressed in any adult tissue, but is expressed in a [...]
Research collaboration leverages Pattern's ProSpectral™ multi-disease hyperspectral diagnostics research platform Potentially ushers in a new era of early detection cancer screening REDMOND, WA, August 21, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Pattern and [...]
Targets high-grade serous ovarian cancer, the most common and deadliest form of gynecologic cancer Underscores potential of Pattern Discovery Engine™ to uncover novel therapeutic combinations for hard-to-treat cancers REDMOND, WA, July 30, 2024 -- Pattern Computer®, Inc. ("Pattern" or [...]
New paper on sensing research collaboration with national labs available on medRxiv Hyperspectral sensing shown to enable agnostic reagent-free diagnostics Study addresses clear and critical need for pathogen agnostic diagnostics that can be quickly and effectively performed at point [...]
Continued expansion of Pattern's IP portfolio Significant progress in expanding industry-leading oncology pipeline REDMOND, WA, June 12, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") announced at the Bio International Conference in San Diego that it is filing [...]
REDMOND, WA, May 22, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer (HGSOC) program. Armed with a [...]
REDMOND, WA, April 3, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Mark R. Anderson, Chairman and CEO, Matt Keener, CTO, and Nidhi Singh, Ph.D., Managing Director, Product Strategy/Sales will participate in the Life Science [...]
REDMOND, WA, January 2, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Mark R. Anderson, Chairman and CEO, is scheduled to present at the Biotech Showcase™ 2024 investor forum, taking place January 8-10, 2024 at [...]